BioArctic AB (BIOAb)

Stockholm
Currency in SEK
197.4000
-0.6000(-0.30%)
Real-time Data

BIOAb Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-92.34-140.46-31.64309.69
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-128.22%-52.11%+77.48%+1,078.9%
aa.aaaa.aaaa.aaaa.aaaa.aa-68.52-119.79-11.18229.25
aa.aaaa.aaaa.aaaa.aaaa.aa11.0113.0514.087.44
aa.aaaa.aaaa.aaaa.aaaa.aa----
aa.aaaa.aaaa.aaaa.aaaa.aa-61.39-28.65-59.4559.85
aa.aaaa.aaaa.aaaa.aaaa.aa26.56-5.0624.9113.15
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-12.52-4.41-12.76-507.49
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-6.6-7.39-2.8114.06
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-112.83-151.54-43.02-193.82
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
aa.aaaa.aaaa.aaaa.aaaa.aa1,112.77999.94848.41805.39
aa.aaaa.aaaa.aaaa.aaaa.aa999.94848.41805.39611.57
aa.aaaa.aaaa.aaaa.aaaa.aa-70.21-91.07-34.44210.92
aa.aaaa.aaaa.aaaa.aaaa.aa-122.78%-29.71%+62.18%+712.39%
aa.aaaa.aaaa.aaaa.aaaa.aa-1.25%-1.38%-0.19%1.28%
* In Millions of SEK (except for per share items)